Renergen Ltd (RLT) - Total Liabilities

Latest as of August 2025: AU$1.70 Billion AUD ≈ $1.20 Billion USD

Based on the latest financial reports, Renergen Ltd (RLT) has total liabilities worth AU$1.70 Billion AUD (≈ $1.20 Billion USD) as of August 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Renergen Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Renergen Ltd - Total Liabilities Trend (2013–2025)

This chart illustrates how Renergen Ltd's total liabilities have evolved over time, based on quarterly financial data.

Renergen Ltd Competitors by Total Liabilities

The table below lists competitors of Renergen Ltd ranked by their total liabilities.

Company Country Total Liabilities
Pricer AB (publ)
ST:PRIC-B
Sweden Skr1.03 Billion
Dana Brata Luhur PT
JK:TEBE
Indonesia Rp63.74 Billion
Decidr Ai Industries Ltd
AU:DAI
Australia AU$14.88 Million
BIEN SPAREB.AS NK 34375
F:JX0
Germany €5.36 Billion
Ratchaphruek Hospital Public Company Limited
BK:RPH
Thailand ฿208.10 Million
R. Stahl AG NA O.N.
F:RSL2
Germany €206.67 Million
Micropolis Holding Company
NYSE:MCRP
USA $40.58 Million
IX Acquisition Corp
NASDAQ:IXAQ
USA $13.70 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Renergen Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Renergen Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.18 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.09 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.94 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.64 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Renergen Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Renergen Ltd (2013–2025)

The table below shows the annual total liabilities of Renergen Ltd from 2013 to 2025.

Year Total Liabilities Change
2025-02-28 AU$1.23 Billion
≈ $873.53 Million
-11.06%
2024-02-29 AU$1.39 Billion
≈ $982.12 Million
+30.86%
2023-02-28 AU$1.06 Billion
≈ $750.50 Million
+20.75%
2022-02-28 AU$878.38 Million
≈ $621.51 Million
+53.04%
2021-02-28 AU$573.95 Million
≈ $406.11 Million
+51.33%
2020-02-29 AU$379.26 Million
≈ $268.35 Million
+523.00%
2019-02-28 AU$60.88 Million
≈ $43.07 Million
+33.53%
2018-02-28 AU$45.59 Million
≈ $32.26 Million
+28.00%
2017-02-28 AU$35.62 Million
≈ $25.20 Million
+18.32%
2016-02-29 AU$30.10 Million
≈ $21.30 Million
-57.93%
2015-02-28 AU$71.55 Million
≈ $50.63 Million
+4.86%
2014-02-28 AU$68.23 Million
≈ $48.28 Million
+9.87%
2013-02-28 AU$62.11 Million
≈ $43.94 Million
--

About Renergen Ltd

AU:RLT Australia Oil & Gas E&P
Market Cap
$82.34 Million
AU$116.38 Million AUD
Market Cap Rank
#19770 Global
#645 in Australia
Share Price
AU$0.75
Change (1 day)
+0.00%
52-Week Range
AU$0.71 - AU$1.45
All Time High
AU$3.99
About

Renergen Limited, an investment holding company, engages in the alternative and renewable energy businesses in South Africa and sub-Saharan Africa. It operates through Tetra4 and Cryovation segments. The company explores for, develops, and sells liquefied natural gas and helium gas. It also develops Cryo-Vacc technology, which enables the transportation of vaccines and biologics at low temperatur… Read more